Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Acutus Medical Inc

Healthcare US AFIB

0.0002USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.00050.0005
LowHigh

52 Week Range

-0.04
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap0.00598M
  • Volume10000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.12600M
  • Revenue TTM20.16M
  • Revenue Per Share TTM0.68
  • Gross Profit TTM 1.01M
  • Diluted EPS TTM-0.15

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -4.53600M -11.85800M -39.53400M -117.68300M -101.95800M
Minority interest - - - - -
Net income -9.54700M -81.66300M -39.61600M -123.36000M -101.98100M
Selling general administrative 10.44M 35.73M 47.65M 63.52M 50.36M
Selling and marketing expenses - - - - -
Gross profit 1.01M -3.13700M -15.54700M -15.66200M -7.42500M
Reconciled depreciation 1.03M 5.79M 7.13M 6.89M 3.90M
Ebit 1.22M -6.20300M -27.33900M -112.12200M -91.33300M
Ebitda 2.25M -5.32900M -83.35700M -108.86200M -86.89600M
Depreciation and amortization 1.03M 0.87M -56.01800M 3.26M 4.44M
Non operating income net other - - - - -5.17200M
Operating income -0.05700M -14.36100M -27.33900M -112.12200M -91.33300M
Other operating expenses 20.21M 21.52M 107.72M 133.13M 99.70M
Interest expense 5.76M 5.66M 5.15M 5.68M 5.51M
Tax provision 0.00000M 0.16M 0.08M 0.00000M 0.02M
Interest income 0.76M 2.80M 0.87M 0.12M 0.44M
Net interest income -4.99500M -2.65000M -4.28100M -5.56100M -5.07000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.01M 0.06M 0.08M 5.68M 0.02M
Total revenue 20.16M 7.16M 16.36M 17.26M 8.46M
Total operating expenses 1.07M 11.22M 75.81M 100.21M 83.81M
Cost of revenue 19.14M 10.30M 31.91M 32.92M 15.89M
Total other income expense net -4.47900M 2.50M -12.19500M -5.56100M -10.62500M
Discontinued operations - - - - -
Net income from continuing ops -4.53600M -32.79000M -39.61600M -117.68300M -101.98100M
Net income applicable to common shares - - -39.61600M -117.68300M -101.98100M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 28.65M 53.96M 133.44M 169.79M 192.53M
Intangible assets - - 1.58M 5.01M 5.65M
Earning assets - - - - -
Other current assets 1.89M 1.19M 7.24M 5.48M 5.20M
Total liab 40.24M 54.84M 58.42M 64.07M 65.95M
Total stockholder equity -11.59200M -0.87900M 75.02M 105.73M 126.58M
Deferred long term liab - - - - -
Other current liab 3.20M 13.60M 14.51M 10.20M 12.41M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -609.52400M -599.97700M -518.31400M -478.69800M -361.01500M
Other liab - - 0.01M 0.55M 3.90M
Good will - - 0.00000M 12.03M 12.03M
Other assets - 0.00000M 0.90M 1.15M 0.72M
Cash 14.02M 26.20M 25.58M 24.07M 25.23M
Cash and equivalents - - - - -
Total current liabilities 12.44M 18.94M 19.87M 18.51M 21.91M
Current deferred revenue - - 0.33M 0.40M 0.30M
Net debt 21.75M 12.28M 13.27M 21.33M 15.84M
Short term debt 7.96M 2.58M 0.32M 0.40M 0.93M
Short long term debt 7.00M 1.86M - - -
Short long term debt total 35.76M 38.48M 38.86M 45.40M 41.08M
Other stockholder equity 598.67M 599.93M 594.17M 584.61M 294.75M
Property plant equipment - - 13.09M 18.19M 14.03M
Total current assets 25.58M 46.25M 117.87M 126.29M 151.39M
Long term investments - - 0.00000M 7.12M 8.73M
Net tangible assets - - 73.44M 88.69M 108.90M
Short term investments 0.00000M 3.23M 44.86M 76.70M 105.84M
Net receivables 7.88M 11.35M 21.09M 3.63M 2.16M
Long term debt 25.56M 32.65M 34.43M 40.41M 39.01M
Inventory 1.79M 4.28M 13.33M 16.41M 12.96M
Accounts payable 1.28M 2.76M 4.72M 7.52M 8.27M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.76800M -0.86600M -0.86900M -0.21700M 0.28M
Additional paid in capital - - - - -
Common stock total equity - - - - 0.03M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -361.01500M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.09M 3.69M 0.90M 1.15M 0.72M
Deferred long term asset charges - - - - -
Non current assets total 3.07M 7.71M 15.57M 43.50M 41.15M
Capital lease obligations 3.19M 3.96M 4.42M 4.99M 2.07M
Long term debt total - - - - 39.01M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 22.15M 59.55M 104.75M 19.07M -52.59900M
Change to liabilities - - -2.85200M -0.87100M 2.28M
Total cashflows from investing activities 22.15M 58.55M 104.75M 19.07M -63.82400M
Net borrowings -2.62500M 0.00000M -9.72500M -9.72500M -9.72500M
Total cash from financing activities -2.89100M -2.66400M -12.11600M 79.57M 164.43M
Change to operating activities - - 3.32M 2.43M -2.59300M
Net income -4.53600M -39.61600M -39.61600M -117.68300M -101.98100M
Change in cash -12.18100M -5.14800M 7.13M -1.16300M 15.78M
Begin period cash flow 26.20M 31.35M 24.22M 25.38M 9.60M
End period cash flow 14.02M 26.20M 31.35M 24.22M 25.38M
Total cash from operating activities -31.66000M -63.11800M -85.03200M -99.68200M -85.16900M
Issuance of capital stock - - 0.00000M 82.66M 166.29M
Depreciation 1.03M 0.87M 7.13M 6.89M 3.90M
Other cashflows from investing activities 0.23M -1.21100M - - -
Dividends paid - - - - -
Change to inventory 2.49M -2.48400M 3.08M -3.87200M -3.89100M
Change to account receivables -4.04800M -1.07400M -0.45200M -1.47300M -1.89700M
Sale purchase of stock - -0.11100M -0.11100M - 166.93M
Other cashflows from financing activities -0.26600M -2.69300M 33.54M -3.08800M -1.85300M
Change to netincome - - -51.78900M 13.49M 18.24M
Capital expenditures 0.11M 0.22M 3.98M 9.97M 11.22M
Change receivables - - - - -1.89700M
Cash flows other operating - - - - 1.41M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - 15.44M
Change in working capital -4.00900M 0.92M -1.60600M -3.78800M -6.09800M
Stock based compensation 0.46M 3.03M 9.39M 13.75M 12.10M
Other non cash items -24.60100M -28.32400M -60.33000M -0.16000M 0.86M
Free cash flow -31.77200M -63.33700M -89.01500M -109.65500M -96.39400M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AFIB
Acutus Medical Inc		 - -% 0.0002 - - 0.0003 0.16 1.08 9.67
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Acutus Medical Inc

2210 Faraday Avenue, Carlsbad, CA, United States, 92008

Key Executives

Name Title Year Born
Mr. R. Scott Huennekens CPA, M.B.A. Exec. Chairman 1964
Mr. David Harrison Roman CEO, Pres & Director 1982
Mr. Vincent J. Burgess Consultant 1965
Mr. Takeo Mukai VP of Fin. & Accounting and Interim CFO NA
Dr. Graydon E. Beatty Chief Technology Officer 1957
Dr. Derrick Chou Ph.D. Chief Technology Officer NA
Mr. Tom Sohn Sr. VP, Gen. Counsel & Sec. 1975
Mr. Shibaji Shome Ph.D. VP of Marketing NA
Mr. Charlie Piscitello Sr. VP & Chief People Officer 1963
Mr. Gary W. Doherty Sr. VP of Fin. 1966

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions